BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16189167)

  • 1. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases.
    Libé R; Bertherat J
    Eur J Endocrinol; 2005 Oct; 153(4):477-87. PubMed ID: 16189167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
    Bertherat J; Gimenez-Roqueplo AP
    Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
    Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of adrenocortical cancer.
    Bertherat J; Bertagna X
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):261-71. PubMed ID: 19500768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectives.
    Bertherat J; Groussin L; Bertagna X
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):632-41. PubMed ID: 17082810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diseases Predisposing to Adrenocortical Malignancy (Li-Fraumeni Syndrome, Beckwith-Wiedemann Syndrome, and Carney Complex).
    Jouinot A; Bertherat J
    Exp Suppl; 2019; 111():149-169. PubMed ID: 31588532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal pathophysiology: lessons from the Carney complex.
    Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
    Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic aspects of adrenocortical tumours and hyperplasias.
    Mazzuco TL; Durand J; Chapman A; Crespigio J; Bourdeau I
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):1-10. PubMed ID: 22471738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase A alterations in adrenocortical tumors.
    Espiard S; Ragazzon B; Bertherat J
    Horm Metab Res; 2014 Nov; 46(12):869-75. PubMed ID: 25105543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
    Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
    Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocortical tumorigenesis: Lessons from genetics.
    Kamilaris CDC; Hannah-Shmouni F; Stratakis CA
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101428. PubMed ID: 32507359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of adrenocortical tumors: Carney complex.
    Stratakis CA
    Ann Endocrinol (Paris); 2001 Apr; 62(2):180-4. PubMed ID: 11353891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal cortical tumors and multiple endocrine neoplasia-related syndromes.
    Haase M; Willenberg HS
    Minerva Endocrinol; 2009 Jun; 34(2):123-35. PubMed ID: 19471237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in adrenocortical tumors.
    Reincke M
    Horm Metab Res; 1998; 30(6-7):447-55. PubMed ID: 9694578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of Cushing's syndrome.
    Yaneva M; Vandeva S; Zacharieva S; Daly AF; Beckers A
    Neuroendocrinology; 2010; 92 Suppl 1():6-10. PubMed ID: 20829611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocorticotropic hormone-independent Cushing's syndrome.
    Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist].
    Tissier F
    Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
    Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.